Marco Le Grazie

454 total citations
12 papers, 308 citations indexed

About

Marco Le Grazie is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marco Le Grazie has authored 12 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Marco Le Grazie's work include Gallbladder and Bile Duct Disorders (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Inflammatory Bowel Disease (4 papers). Marco Le Grazie is often cited by papers focused on Gallbladder and Bile Duct Disorders (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Inflammatory Bowel Disease (4 papers). Marco Le Grazie collaborates with scholars based in Italy, Canada and Taiwan. Marco Le Grazie's co-authors include Andrea Galli, Simone Polvani, Mirko Tarocchi, Maria Rosa Biagini, Armando Gabbrielli, Laura Bernardoni, Maria Cristina Conti Bellocchi, Stefano Francesco Crinò, Alice Parisi and Alberto Larghi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastrointestinal Endoscopy and Endoscopy.

In The Last Decade

Marco Le Grazie

12 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Le Grazie Italy	7	128	108	100	88	57	12	308
Silvia Camera Italy	10	164 1.3×	75 0.7×	67 0.7×	96 1.1×	102 1.8×	27	388
Yoshinari Maeda Japan	8	162 1.3×	84 0.8×	52 0.5×	73 0.8×	38 0.7×	29	302
Xiaoju Shi China	13	128 1.0×	77 0.7×	53 0.5×	126 1.4×	88 1.5×	35	415
Kazuya Ofuji Japan	10	88 0.7×	77 0.7×	49 0.5×	55 0.6×	43 0.8×	35	248
Chun‐Hui Nie China	11	61 0.5×	100 0.9×	63 0.6×	64 0.7×	68 1.2×	31	333
Yulin Tan China	11	162 1.3×	73 0.7×	139 1.4×	94 1.1×	32 0.6×	29	399
Barbara Tagliaferri Italy	10	180 1.4×	72 0.7×	160 1.6×	45 0.5×	26 0.5×	34	334
Jiashuo Chao China	9	116 0.9×	60 0.6×	45 0.5×	74 0.8×	32 0.6×	20	255
Lei Cai China	10	71 0.6×	51 0.5×	103 1.0×	157 1.8×	33 0.6×	30	308
Huarong Tang China	12	116 0.9×	128 1.2×	113 1.1×	118 1.3×	22 0.4×	36	354

Countries citing papers authored by Marco Le Grazie

Since Specialization

Citations

This map shows the geographic impact of Marco Le Grazie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Le Grazie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Le Grazie more than expected).

Fields of papers citing papers by Marco Le Grazie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Le Grazie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Le Grazie. The network helps show where Marco Le Grazie may publish in the future.

Co-authorship network of co-authors of Marco Le Grazie

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Le Grazie. A scholar is included among the top collaborators of Marco Le Grazie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Le Grazie. Marco Le Grazie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Grazie, Marco Le. (2021). Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study. Annals of Gastroenterology. 34(3). 370–377. 7 indexed citations

Bellocchi, Maria Cristina Conti, Stefano Francesco Crinò, Marco Le Grazie, et al.. (2021). Reappraisal of factors impacting the cannulation rate and clinical efficacy of endoscopic minor papilla sphincterotomy. Pancreatology. 21(4). 805–811. 2 indexed citations

Valdivia, Pablo Cortegoso, Marco Le Grazie, Federica Gaiani, Raffaele Dalla Valle, & Gian Luigi de’Angelis. (2021). Bouveret syndrome in a cholecystoduodenal fistula. SHILAP Revista de lepidopterología. 9(4). 2485–2486. 4 indexed citations

Grazie, Marco Le, Stefano Francesco Crinò, Armando Gabbrielli, et al.. (2020). Pancreatico-gastric fistula mimicking malignant infiltration following transgastric EUS-FNA of resectable pancreatic ductal adenocarcinoma. Endoscopic Ultrasound. 9(2). 138–138. 1 indexed citations

Crinò, Stefano Francesco, Marco Le Grazie, Erminia Manfrin, et al.. (2020). Randomized trial comparing fork-tip and side-fenestrated needles for EUS-guided fine-needle biopsy of solid pancreatic lesions. Gastrointestinal Endoscopy. 92(3). 648–658.e2. 50 indexed citations

Ribaldone, Davide Giuseppe, Nicola Imperatore, Marco Le Grazie, et al.. (2020). Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study. Digestive and Liver Disease. 53(6). 712–716. 5 indexed citations

Sansone, Vito, Marco Le Grazie, Simone Polvani, et al.. (2020). Telomerase reactivation is associated with hepatobiliary and pancreatic cancers. Hepatobiliary & pancreatic diseases international. 19(5). 420–428. 7 indexed citations

Grazie, Marco Le, Maria Cristina Conti Bellocchi, Laura Bernardoni, et al.. (2020). Diagnostic yield of endoscopic ultrasound-guided tissue acquisition of solid pancreatic lesions after inconclusive percutaneous ultrasound-guided tissue acquisition. Scandinavian Journal of Gastroenterology. 55(9). 1108–1113. 2 indexed citations

Dragoni, Gabriele, Siro Bagnoli, Marco Le Grazie, et al.. (2019). Long‐term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real‐life experience from a tertiary referral center. Journal of Digestive Diseases. 20(5). 235–242. 11 indexed citations

10.

Dragoni, Gabriele, et al.. (2018). Golimumab in inflammatory bowel diseases: present and future scenarios. Clinical Journal of Gastroenterology. 12(1). 1–9. 6 indexed citations

11.

Grazie, Marco Le, Maria Rosa Biagini, Mirko Tarocchi, Simone Polvani, & Andrea Galli. (2017). Chemotherapy for hepatocellular carcinoma: The present and the future. World Journal of Hepatology. 9(21). 907–907. 158 indexed citations

12.

Mariani, Alberto, Milena Di Leo, Nicola Giardullo, et al.. (2016). Early precut sphincterotomy for difficult biliary access to reduce post-ERCP pancreatitis: a randomized trial. Endoscopy. 48(6). 530–535. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact